Author

V. Vemulapalli

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

S. C. Blacklow· 2 shared A. Erickson· 1 shared A. Li· 1 shared A. Rivera· 1 shared C. Cabral· 1 shared E. S. Fischer· 1 shared E. Tjon· 1 shared G. Cuny· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

S. C. Blacklow

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The ATLAS™ screening assay reveals distinct CD4+ and CD8+ SARS-CoV-2 antigen response profiles which have implications to Omicron cellular immunity

J. J. Foti, K. Lema, J. Strickland, E. Tjon, A. Li, A. Rivera, C. Cabral, L. Cormier, L. Dowal, S. Rao, V. Vemulapalli, J. B. Flechtner

The paper uses the ATLAS assay to identify CD4+ and CD8+ T cell antigen responses to SARS-CoV-2 variants, revealing common epitopes and predicting Omicron spike mutation impacts.

bioRxiv · May 17, 2022 · PreprintImmunology

Targeted degradation of the oncogenic phosphatase SHP2

V. Vemulapalli, K. A. Donovan, T. Seegar, J. M. Rogers, M. Bae, R. Lumpkin, R. Cao, M. Henke, E. S. Fischer, G. Cuny, S. C. Blacklow

This paper develops a SHP2 PROTAC that degrades SHP2 in leukemic cells, inhibits MAPK signaling, and suppresses cancer growth.

bioRxiv · Jun 2, 2021 · PreprintBiochemistry

Time resolved quantitative phosphoproteomics reveals distinct patterns of SHP2 dependence in EGFR signaling

V. Vemulapalli, L. Chylek, A. Erickson, J. LaRochelle, K. Subramanian, M. Mohseni, M. LaMarche, M. G. Acker, P. K. Sorger, S. P. Gygi, S. C. Blacklow

The paper uses time-resolved phosphoproteomics to analyze SHP2's role in EGFR signaling, identifying distinct phosphotyrosine response patterns upon SHP099 treatment.

bioRxiv · Apr 12, 2019 · PreprintCell Biology